These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24403510)

  • 1. Characterization of and protection from neurotoxicity induced by oxaliplatin, bortezomib and epothilone-B.
    Ceresa C; Avan A; Giovannetti E; Geldof AA; Avan A; Cavaletti G; Peters GJ
    Anticancer Res; 2014 Jan; 34(1):517-23. PubMed ID: 24403510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation.
    Verstappen CC; Postma TJ; Geldof AA; Heimans JJ
    Anticancer Res; 2004; 24(4):2337-41. PubMed ID: 15330181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pivotal role of intracellular calcium in oxaliplatin-induced inhibition of neurite outgrowth but not cell death in differentiated PC12 cells.
    Takeshita M; Banno Y; Nakamura M; Otsuka M; Teramachi H; Tsuchiya T; Itoh Y
    Chem Res Toxicol; 2011 Nov; 24(11):1845-52. PubMed ID: 21981408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity.
    Kobrinsky B; Joseph SO; Muggia F; Liebes L; Beric A; Malankar A; Ivy P; Hochster H
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):1073-8. PubMed ID: 24048674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.
    Verstappen CC; Geldof AA; Postma TJ; Heimans JJ
    J Neurooncol; 1999 Aug; 44(1):1-5. PubMed ID: 10582662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic effect of amifostine on oxaliplatin-related neurotoxicity in patients with digestive tract tumors].
    Lu P; Fan QX; Wang LX; Wang X; Zong H; Wang RL
    Ai Zheng; 2008 Oct; 27(10):1117-20. PubMed ID: 18851795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells.
    Mendonça LM; da Silva Machado C; Teixeira CC; de Freitas LA; Bianchi Mde L; Antunes LM
    Neurotoxicology; 2013 Jan; 34():205-11. PubMed ID: 23036615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CyclinB2 and BIRC5 genes as surrogate biomarkers for neurite outgrowth in SH-SY5Y subclonal cells.
    Oe T; Nagashima T; Muramoto M; Yamazaki T; Morikawa N; Okitsu O; Nishimura S; Aoki T; Katayama Y; Kita Y
    Neuropharmacology; 2006 Jun; 50(8):1041-7. PubMed ID: 16574167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Bcl-xL/Beclin-1 in interplay between apoptosis and autophagy in oxaliplatin and bortezomib-induced cell death.
    Kim SY; Song X; Zhang L; Bartlett DL; Lee YJ
    Biochem Pharmacol; 2014 Mar; 88(2):178-88. PubMed ID: 24486574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous extract of Lithospermi radix attenuates oxaliplatin-induced neurotoxicity in both in vitro and in vivo models.
    Cho ES; Yi JM; Park JS; Lee YJ; Lim CJ; Bang OS; Kim NS
    BMC Complement Altern Med; 2016 Oct; 16(1):419. PubMed ID: 27782842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy?
    Di Cesare Mannelli L; Zanardelli M; Failli P; Ghelardini C
    Free Radic Biol Med; 2013 Aug; 61():143-50. PubMed ID: 23548635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial Protection of Paclitaxel-induced Neurotoxicity by Antioxidants.
    Hara Y; Sakagami H; Shi H; Abe T; Tamura N; Takeshima H; Horie N; Kaneko T; Shiratsuchi H; Kaneko T
    In Vivo; 2018; 32(4):745-752. PubMed ID: 29936454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat.
    Robinson CR; Zhang H; Dougherty PM
    Neuroscience; 2014 Aug; 274():308-17. PubMed ID: 24905437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic neuropathy.
    Umapathi T; Chaudhry V
    Curr Opin Neurol; 2005 Oct; 18(5):574-80. PubMed ID: 16155443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental epothilone B neurotoxicity: results of in vitro and in vivo studies.
    Chiorazzi A; Nicolini G; Canta A; Oggioni N; Rigolio R; Cossa G; Lombardi R; Roglio I; Cervellini I; Lauria G; Melcangi RC; Bianchi R; Crippa D; Cavaletti G
    Neurobiol Dis; 2009 Aug; 35(2):270-7. PubMed ID: 19464369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats.
    Meregalli C; Canta A; Carozzi VA; Chiorazzi A; Oggioni N; Gilardini A; Ceresa C; Avezza F; Crippa L; Marmiroli P; Cavaletti G
    Eur J Pain; 2010 Apr; 14(4):343-50. PubMed ID: 19695912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model.
    Alé A; Bruna J; Morell M; van de Velde H; Monbaliu J; Navarro X; Udina E
    Exp Neurol; 2014 Mar; 253():165-73. PubMed ID: 24406455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of Bortezomib-induced Neurotoxicity by Antioxidants.
    Iijima Y; Bandow K; Amano S; Sano M; Hino S; Kaneko T; Horie N; Sakagami H
    Anticancer Res; 2020 Jul; 40(7):3685-3696. PubMed ID: 32620607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells.
    Duechler M; Linke A; Cebula B; Shehata M; Schwarzmeier JD; Robak T; Smolewski P
    Eur J Haematol; 2005 May; 74(5):407-17. PubMed ID: 15813915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons.
    Yasuyoshi H; Kashii S; Zhang S; Nishida A; Yamauchi T; Honda Y; Asano Y; Sato S; Akaike A
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2273-8. PubMed ID: 10892873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.